Literature DB >> 16394132

Transcription factor decoys: a new model for disease intervention.

Michael J Mann1.   

Abstract

Transcription factor proteins regulate gene expression via binding to specific DNA sequences found in the promoter/enhancer regions of the genes they control. Although most transcription factor binding has been associated with an increase in gene expression, gene suppression has also been described. Transcription factor decoys are molecules that mimic the binding sites for transcription factor proteins, and compete with promoter regions to absorb this binding activity in the cell nucleus. By blocking transcription factor-chromosomal DNA interaction, these molecules provide a powerful means to manipulate the regulation of gene expression, particularly as transcription factors are increasingly understood to alter gene activation during the course of normal and pathologic processes in cell biology. As methods for cellular and nuclear delivery of these agents improve, the increasing use of transcription factor decoys, both as investigative and therapeutic tools, promises to have a significant impact on our understanding of and ability to treat human disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16394132     DOI: 10.1196/annals.1359.021

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

Review 1.  Drugging the undruggable: transcription therapy for cancer.

Authors:  Chunhong Yan; Paul J Higgins
Journal:  Biochim Biophys Acta       Date:  2012-11-09

2.  Catch and Release DNA Decoys: Capture and Photochemical Dissociation of NF-κB Transcription Factors.

Authors:  Nicholas B Struntz; Daniel A Harki
Journal:  ACS Chem Biol       Date:  2016-04-07       Impact factor: 5.100

3.  Diverse role of decoys on emergence and precision of oscillations in a biomolecular clock.

Authors:  Supravat Dey; Abhyudai Singh
Journal:  Biophys J       Date:  2021-11-11       Impact factor: 4.033

4.  Targeted delivery of complexes of biotin-PEG-polyethylenimine and NF-kappaB decoys to brain-derived endothelial cells in vitro.

Authors:  Raktima Bhattacharya; Berit Osburg; Dagmar Fischer; Ulrich Bickel
Journal:  Pharm Res       Date:  2007-10-20       Impact factor: 4.200

5.  Salt-sensitive hypertension induced by decoy of transcription factor hypoxia-inducible factor-1alpha in the renal medulla.

Authors:  Ningjun Li; Li Chen; Fan Yi; Min Xia; Pin-Lan Li
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

6.  Optimizing Perioperative Use of Opioids: A Multimodal Approach.

Authors:  Maria F Ramirez; Brinda B Kamdar; Juan P Cata
Journal:  Curr Anesthesiol Rep       Date:  2020-09-07

Review 7.  Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.

Authors:  Leila Farahmand; Behrad Darvishi; Keivan Majidzadeh-A
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Effects of decoy molecules targeting NF-kappaB transcription factors in Cystic fibrosis IB3-1 cells: recruitment of NF-kappaB to the IL-8 gene promoter and transcription of the IL-8 gene.

Authors:  Alessia Finotti; Monica Borgatti; Valentino Bezzerri; Elena Nicolis; Ilaria Lampronti; Maria Dechecchi; Irene Mancini; Giulio Cabrini; Michele Saviano; Concetta Avitabile; Alessandra Romanelli; Roberto Gambari
Journal:  Artif DNA PNA XNA       Date:  2012-04-01

9.  Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sites.

Authors:  William R Swindell; Mrinal K Sarkar; Philip E Stuart; John J Voorhees; James T Elder; Andrew Johnston; Johann E Gudjonsson
Journal:  Clin Transl Med       Date:  2015-03-19

10.  Pharmacological manipulation of transcription factor protein-protein interactions: opportunities and obstacles.

Authors:  Frank Fontaine; Jeroen Overman; Mathias François
Journal:  Cell Regen (Lond)       Date:  2015-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.